Preventing Malaria During Pregnancy in Epidemic-prone Areas.
Malaria, Falciparum
About this trial
This is an interventional prevention trial for Malaria, Falciparum focused on measuring malaria, pregnancy, intermittent preventive treatment, insecticide-treated nets
Eligibility Criteria
Inclusion Criteria: Pregnant women whose pregnancies are at <27 weeks gestation at first antenatal booking Permanent resident in study area Informed consent Exclusion Criteria: Late presentation: pregnancies more than 26 weeks gestation at first antenatal booking Severe anaemia (Hb<70g/L) on enrolment Previous reaction to a sulfa-drug (e.g. sulphadoxine-pyrimethamine, septrin) History of severe skin reaction to any drug Current (or history) of severe disease (e.g. hepatitis, jaundice, TB, AIDS) Withdrawal Criteria: Withdrawal of consent Women developing severe anaemia (Hb<70g/L)during pregnancy
Sites / Locations
- Kabale District Health Services (antenatal clinics at selected sites)
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
1
2
3
Drug: Intermittent preventive treatment:sulphadoxine-pyrimethamine
Device: Insecticide-treated mosquito bed net
Combination of Drug + Device: Drug: Intermittent preventive treatment:sulphadoxine-pyrimethamine Device: Insecticide-treated mosquito bed net